Needham & Company LLC Increases Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target to $20.00

Avadel Pharmaceuticals (NASDAQ:AVDL – Free Report) had its target price lifted by Needham & Company LLC from $19.00 to $20.00 in a report released on Wednesday morning, MarketBeat.com reports. Needham & Company LLC currently has a buy rating on the stock. Avadel Pharmaceuticals Trading Up 1.4 % Shares of NASDAQ AVDL opened at $13.80 on […]

Leave a Reply

Your email address will not be published.

Previous post Apogee Therapeutics (NASDAQ:APGE) Earns Buy Rating from Analysts at BTIG Research
Next post Costco Wholesale (NASDAQ:COST) Downgraded by StockNews.com